TGFB1 and breast cancer: The ability of the microtubule destabilizers and, in some cell lines, ixabepilone, but not paclitaxel, to inhibit TGF-β-induced SNAI1 and Snail expression could be important for their clinical efficacy, especially in breast cancer patients whose tumours have undergone EMT.